Page last updated: 2024-12-08

lunularic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

lunularic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID161413
CHEMBL ID240495
CHEBI ID6567
SCHEMBL ID574679
MeSH IDM0184879

Synonyms (24)

Synonym
6-(p-hydroxyphenethyl)salicylic acid
lunularic acid
23255-59-6
LMPK13090038
CHEMBL240495
chebi:6567 ,
2-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]benzoic acid
benzoic acid, 2-hydroxy-6-(2-(4-hydroxyphenyl)ethyl)-
2-hydroxy-6-(2-(4-hydroxyphenyl)ethyl)benzoic acid
9zq3fyv21c ,
unii-9zq3fyv21c
lunularic acid [mi]
SCHEMBL574679
2-hydroxy-6-(4-hydroxyphenethyl)benzoic acid
DTXSID40177826
AKOS028108643
benzoic acid, 2-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-
AS-69280
lunularsaure
mfcd24368585
Q6704485
YAA25559
2-hydroxy-6-(4-hydroxyphenethyl)benzoicacid
2-(4-HYDROXYPHENETHYL)-6-HYDROXYBENZOIC ACID
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
stilbenoidAny olefinic compound characterised by a 1,2-diphenylethylene backbone.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID348950Antibacterial activity against Streptococcus mutans ATCC 25175 after 2 days by twofold broth dilution method2008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Design and evaluation of anacardic acid derivatives as anticavity agents.
AID300520Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 by broth dilution method2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Molecular design of anti-MRSA agents based on the anacardic acid scaffold.
AID348953Antibacterial activity against Escherichia coli ATCC 9637 up to 200 ug/ml after 2 days by twofold broth dilution method2008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Design and evaluation of anacardic acid derivatives as anticavity agents.
AID300521Antibacterial activity against Escherichia coli ATCC 96372007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Molecular design of anti-MRSA agents based on the anacardic acid scaffold.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's5 (55.56)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.38 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.04 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]